|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 687.65 INR | -0.84% |
|
-6.48% | -7.05% |
| 27/06 | Supriya Lifescience Limited, Q4 2025 Earnings Call, May 28, 2025 | |
| 27/05 | Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 | CI |
| Capitalization | 5.53TCr 65Cr 55Cr 51Cr 48Cr 88Cr 98Cr 615.6Cr 235.37Cr 2.59TCr 241.91Cr 236.93Cr 9.5TCr | P/E ratio 2025 |
31.4x | P/E ratio 2026 * | 28x |
|---|---|---|---|---|---|
| Enterprise value | 5.53TCr 65Cr 55Cr 51Cr 48Cr 88Cr 98Cr 615.6Cr 235.37Cr 2.59TCr 241.91Cr 236.93Cr 9.5TCr | EV / Sales 2025 |
8.48x | EV / Sales 2026 * | 6.62x |
| Free-Float |
27.82% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Supriya Lifescience Limited
| 1 day | -0.84% | ||
| 1 week | -6.48% | ||
| Current month | -3.02% | ||
| 1 month | +1.05% | ||
| 3 months | -3.29% | ||
| 6 months | +3.81% | ||
| Current year | -7.05% |
| 1 week | 682.95 |  | 746.75 |
| 1 month | 651.7 | | 746.75 |
| Current year | 556.15 | | 842 |
| 1 year | 368 | | 842 |
| 3 years | 170.15 | | 842 |
| 5 years | 170.15 | | 842 |
| 10 years | 170.15 | | 842 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 33 | 01/08/2024 | |
| Chief Executive Officer | 35 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 26/03/2008 | |
| Director/Board Member | 40 | 01/06/2019 | |
| Director/Board Member | 35 | 01/06/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.84% | -6.48% | +72.62% | +97.63% | 65Cr | ||
| +0.30% | +1.58% | -15.11% | +139.53% | 71TCr | ||
| -0.50% | +0.57% | +4.81% | -12.03% | 38TCr | ||
| -1.31% | +1.67% | +13.27% | +25.60% | 34TCr | ||
| -3.64% | -2.74% | -54.62% | +8.25% | 31TCr | ||
| -2.36% | -1.23% | +1.86% | -21.34% | 26TCr | ||
| -3.00% | -1.93% | -3.07% | +15.94% | 24TCr | ||
| -1.66% | +1.10% | -13.64% | -6.31% | 22TCr | ||
| -0.79% | +3.00% | -35.36% | -11.60% | 21TCr | ||
| -1.70% | -1.00% | -9.17% | +19.17% | 16TCr | ||
| Average | -1.41% | +0.13% | -3.84% | +25.48% | 28.18TCr | |
| Weighted average by Cap. | -1.25% | +0.64% | -11.77% | +36.75% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 704.2Cr 8.21Cr 7.02Cr 6.54Cr 6.08Cr 11Cr 12Cr 78Cr 30Cr 329.72Cr 31Cr 30Cr 1.21TCr | 836.3Cr 9.75Cr 8.33Cr 7.76Cr 7.22Cr 13Cr 15Cr 93Cr 36Cr 391.57Cr 37Cr 36Cr 1.44TCr |
| Net income | 173.8Cr 2.03Cr 1.73Cr 1.61Cr 1.5Cr 2.77Cr 3.08Cr 19Cr 7.39Cr 81Cr 7.6Cr 7.44Cr 298.49Cr | 197.7Cr 2.3Cr 1.97Cr 1.84Cr 1.71Cr 3.15Cr 3.51Cr 22Cr 8.41Cr 93Cr 8.64Cr 8.46Cr 339.54Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
448
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/25/11 | 687.65 ₹ | -0.84% | 1,98,279 |
| 10/25/10 | 693.45 ₹ | -2.22% | 1,93,590 |
| 09/25/09 | 709.20 ₹ | +0.68% | 2,14,570 |
| 08/25/08 | 704.40 ₹ | -1.31% | 3,20,520 |
| 07/25/07 | 713.75 ₹ | -2.93% | 3,26,031 |
End-of-day quote NSE India S.E., July 11, 2025
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition